首页
外语
计算机
考研
公务员
职业资格
财经
工程
司法
医学
专升本
自考
实用职业技能
登录
外语
Doctors at Stanford University are studying a medication they hope will alleviate the suffering of millions of American women. B
Doctors at Stanford University are studying a medication they hope will alleviate the suffering of millions of American women. B
admin
2013-01-25
54
问题
Doctors at Stanford University are studying a medication they hope will alleviate the suffering of millions of American women. But their target isn’t breast cancer, osteoporosis, or a similarly well-known affliction. Despite its alarming impact on its victims, the malady in question has received comparatively little medical scrutiny. It’s a "hidden epidemic," according to the Stanford researchers: compulsive shopping disorder.
That’s right. What was once merely a punchline in television sitcoms is now being taken seriously by many clinicians. According to the Stanford study’s leader, Dr. Lorrin Koran, compulsive shopping is "motivated by ’irresistible’ impulses, characterized by spending that is excessive and inappropriate, has harmful consequences for the individual, and tends to be chronic and stereotyped." Compulsive shoppers "binge buy" --most often clothes, shoes, makeup, and jewelry--and then suffer intense guilt. That, in turn, helps trigger another frenzied trip to the mall, and the cycle continues.
Could compulsive shopping be a health hazard associated with America’s unparalleled economic prosperity? "It seems to be a disease of affluence," says Dr. Jerrold Pollak, a clinical psychologist who’s treated several shopaholics. "Advertisers... would like us to think that shopping is a reason to live," agrees Dr. Cheryl Carmin, another clinical psychologist. "If you do not have the time or inclination to go to the mall or grocery store, there are catalogs, delivery services, home shopping networks on TV, and endless items to buy via the Internet." Indeed, this year, US advertisers will spend $ 233 billion--an amount equal to six federal education budgets to persuade Americans to buy, buy, buy.
Yet the possibility that US advertisers may be driving certain women in our society t9 psychosis is only part of the story. It seems that the pharmaceutical companies’ quest to cure the effects of excessive marketing may itself be little more than a cleverly-disguised marketing scheme. The Stanford study, like many of its kind, is being funded by a pharmaceutical company. The undisclosed drug is an FDA-approved antidepressant, specifically an SSRI--a selective serotonin re-uptake inhibitor. (The researchers are also studying behavioral therapies for compulsive shoppers.)
The researchers running the Stanford study refused to reveal their sponsor. However, only five SSRIs are currently on the US market. Pfizer (makers of Zolofi), Eli Billy (Prozac) and SmithKline Beecham (Paxil) all reported that they are neither conducting nor planning any studies of their drugs for compulsive shopping. Solvay (Luvox)also seems an unlikely candidate. In 1997, researchers at the University of Iowa tried using Luvox to treat compulsive shoppers and found no measurable differences between the effects of the drug and those of a placebo. Perhaps the manufacturers of Luvox want to give their product another shot. More likely, however, the mysterious benefactor of the Stanford Study is Forest Pharmaceuticals (Celexa). Their PR department neither confirmed nor denied any involvement in Koran’s study.
Why would a pharmaceutical company anonymously spend money to license one of its top-selling drugs for a marginal disorder like compulsive shopping? A big part of the answer is profit. The mystery company presumably hopes to carve a unique slice out of the mental disorder pie in order to market it together with a ready-made treatment. This is not at all a new strategy for the world’s mammoth pharmaceutical firms, as David Healy, a professor at the University of Wales College of Medicine, explains in his book "The Anti- Depressant Em." Healy’s book describes a process by which companies Seek to "educate" both patients and clinicians about a new disorder, to sell the disorder in preparation for selling its cure. Funding clinical trials is a crucial part of that process.
The manufacturer of which of the following SSRIs is most possibly the sponsor of the Stanford study?
选项
A、Zolofi.
B、Prozac.
C、Luvox.
D、Celexa.
答案
D
解析
该题要求理解第五段的内容。不难看出,D项为正确答案。
转载请注明原文地址:https://kaotiyun.com/show/hm1O777K
0
考博英语
相关试题推荐
AstronautJimVosshasenjoyedmanymemorablemomentsinhiscareer,includingthreespaceflightsandonespacewalk.Buthere
Somepeoplewantonlyrealflowersontheirtableswhileothersliketohave________ones.
Farmersaremoreanxiousforrainthanpeopleincitiesbecausetheyhavemoreat______.
Thelocalauthority____thecompanyaninterest-freeloantostartupthenewfactory.
Therearehiddenfactorswhichscientistscall"feedbackmechanisms".Nooneknowsquitehowtheywillinteractwiththechangin
Themanagergaveherhis_____thatthecomplaintwouldbeinvestigated.
Therearegreatcareersinwhichtheincreasingemphasisisonspecialization.Youfindthesecareersinengineering,inproduct
Hurricanesareviolentstormsthatcausemillionsofdollarsinpropertydamageandtakemanylives.Theycanbeextremelydange
Thewaythatpeoplespendtheirmoney,andtheobjectsonwhichtheyspendit,arethelastareaswherefreechoiceandindividu
Thepursuitwas______whenitwasclearthatwehadwontheday.
随机试题
英语中用数词修饰名词,汉语中数词加名词,中间常加入_____来修饰名词。
Thecurrent_________ofrepackagedmusicunderMilesDavis’namemightpromptanyreasonablepersontoconcludethattherecordin
A.呆小病B.性成熟延迟C.佝偻病D.克山病E.贫血硒缺乏可导致
以下肝硬化的主要并发症哪项不正确
A.奥美拉唑B.地塞米松C.枸橼酸铋钾D.阿托品E.三硅酸镁宜于餐前0.5~1小时服用的胃黏膜保护药是()。
2012年7月,A市甲招标代理机构公司与乙国有建设单位签订了《委托招标代理合同》,由甲招标代理公司负责乙建设单位H办公楼设计、监理和施工招标,H写字楼总建筑面积约55万平方千米,总投资约60亿元。2012年8月,甲招标代理公司与乙建设单位又就H办公楼工作招
活动支架可分为()几种形式。
小李虽然不是科班______,但他在外国文学方面的造诣足以使专业人士______。填入横线部分最恰当的一项是()。
科技资源的分散不仅无法保障科技投入的使用效率,更重要的是无法让有限的科技资源聚焦国家战略决策和重大部署,推动我国科技在重大关键领域的跨越式进步。培育和发展战略性新兴产业是我国当前面临的重大战略机遇。每一个新兴产业领域的推进都是一项系统工程,不仅要选择好方向
已知f(x)具有任意阶导数,且f’(x)=[f(x)]2,求f(n)(x)(其中n≥1的整数).
最新回复
(
0
)